Ozempic, Wegovy and other GLP-1 medications could help extremely obese patients drop enough pounds to be eligible for ...
T hree months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped ...
New research finds that metabolic and bariatric surgery is more effective for long-term weight loss than lifestyle changes ...
GLP-1 drugs such as Wegovy, Ozempic, and Zepbound are a class of medications primarily taken to treat Type 2 diabetes and, more recently, obesity. Research indicates many people taking GLP-1s for ...
Blue Cross Blue Shield of Michigan is one such insurer. Beginning in January 2025, around 10,000 people in the state will ...
These are the most common side effects and changes you may experience in the days and weeks after you stop taking GLP-1 drugs ...
Thousands of people in Michigan who use popular weight loss drugs will soon lose their coverage for it. Blue Cross Blue ...
Systematic reviews of medical literature between 2020 to 2024 show bariatric surgery, also known as metabolic or weight-loss surgery, produces the greatest and most sustained weight loss compared to ...
Blue Cross Blue Shield of Michigan will drop coverage GLP-1 obesity drugs in fully insured large group commercial plans ...
Blue Cross Blue Shield of Michigan reportedly plans to drop coverage of GLP-1 obesity drugs for certain plans due to concerns ...
Weight-loss drugs from Novo Nordisk A/S and Eli Lilly and Co. will lose coverage under many plans run by Michigan’s largest ...